One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
BREAKING: FDA approves Breyanzi for earlier lymphoma use
Breyanzi, a CAR T-cell therapy approved for non-Hodgkin lymphoma, is now available to patients after one other treatment fails.
New documentary about historic CAR T-cell trial and first child patient
Documentary features Carl June, MD, survivor Emily Whitehead, and others. It's available for streaming June 14.
Top 3 challenges for cell and gene therapy against solid tumors
Solid tumors pose unique challenges to using cell and gene therapy. There are solutions, though.
ACGT scientist behind CAR T-cell breakthrough for gastrointestinal cancers
Carl June, MD, and others at Penn Medicine identified a protein target expressed on many gastrointestinal cancers.
What is cancer gene therapy?
Here's an explanation of how gene therapy is used to treat cancer, plus the types of gene therapy and steps.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
31.5
million dollars awarded to groundbreaking research.
61
research fellows supported.
36
of the top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Sidi Chen, PhD
Yale University School of Medicine
Taking on the challenges of pancreatic cancer with an innovative, versatile and highly scalable CRISPRa strategy.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Sidi Chen, PhD
Yale University School of Medicine
Taking on the challenges of pancreatic cancer with an innovative, versatile and highly scalable CRISPRa strategy.
Stay up-to-date with us and get involved.
Jun 13, 2022
Jun 14, 2022
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today